Роль микроРНК в онкогенезе опухолей гипофиза и их практическая значимость
- Авторы: Лапшина АМ1, Хандаева ПМ1, Белая ЖЕ1, Рожинская ЛЯ1, Мельниченко ГА1
-
Учреждения:
- Эндокринологический научный центр Минздрава России
- Выпуск: Том 88, № 8 (2016)
- Страницы: 115-120
- Раздел: Передовая статья
- Статья получена: 10.04.2020
- Статья опубликована: 15.08.2016
- URL: https://ter-arkhiv.ru/0040-3660/article/view/32116
- DOI: https://doi.org/10.17116/terarkh2016888115-120
- ID: 32116
Цитировать
Полный текст
Аннотация
Ключевые слова
Об авторах
А М Лапшина
Эндокринологический научный центр Минздрава РоссииМосква, Россия
П М Хандаева
Эндокринологический научный центр Минздрава РоссииМосква, Россия
Ж Е Белая
Эндокринологический научный центр Минздрава РоссииМосква, Россия
Л Я Рожинская
Эндокринологический научный центр Минздрава РоссииМосква, Россия
Г А Мельниченко
Эндокринологический научный центр Минздрава РоссииМосква, Россия
Список литературы
- Ezzat S, Asa SL, Coldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004;101(3):613-619. doi: 10.1002/cncr.20412
- Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab. 2006;91(12):4769-4775. doi: 10.1210/jc.2006-1668
- Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 2010;72(3):377-382. doi: 10.1016/s0084-3873(10)79801-1
- Monson JP. The epidemiology of endocrine tumors. Endocrine-Related Cancer. 2000;7(1):29-36. doi: 10.1677/erc.0.0070029
- Roelfsema F, Biermasz NR, Pereira AM. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary. 2012;15(1):71-83. doi: 10.1007/s11102-011-0347-7
- Дедов И.И., Белая Ж.Е., Ситкин И.И., Марова Е.И., Пржиялковская Е.Г., Ремизов О.В., Рожинская Л.Я. Значение метода селективного забора крови из нижних каменистых синусов в дифференциальной диагностике АКТГ-зависимого гиперкортицизма. Проблемы эндокринологии. 2009;55:35-40. doi: 10.14341/probl200955635-40
- Белая Ж.Е., Рожинская Л.Я., Мельниченко Г.А., Дедов И.И. Современный взгляд на скрининг и диагностику эндогенного гиперкортицизма. Проблемы эндокринологии. 2012;58:35-41. doi: 10.14341/probl201258435-41
- Plotz D, Knowlton AL, Ragan C. The natural history of Cushing’s disease. Am J Med. 1952;13:597-614.
- Pivonello R, Melnichenko G, Zacharieva S, Gu F, Oscar B, Shah NS, Gaillard R, Colao A. Endocrine abstracts. 2011;26:32-35. Available at: http://www.endocrine-abstracts.org/ea/0026/AbstractBook.aspx
- Клиническая нейроэндокринология. Под ред. акад. РАН Дедова И.И. М.: Издательство УП-ПРИНТ; 2011.
- Wass JA, Karavitaki N. Nonfunctioning pituitary adenomas: the Oxford experiences. Nature Rev Endocrinol. 2009;5(9):519-522. doi: 10.1038/nrendo.2009.147
- Kazunori A. Short and long term effects of trassphenoidal surgery on growth hormone producing pituitary adenomas: based on the experiences with 290 patients. Endocrine Journal. International Congress of Endocrinology. 2010;57(2):280.
- Mete O, Asa SL. Clinicopathological correlations in pituitary adenomas. Brain Pathol J. 2012;22(4):443-453. doi: 10.1111/j.1750-3639.2012.00599.x
- Filipowicz W, Bhattacharyya SN, Sonenburg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics. 2008;9:102-104. doi: 10.1038/nrg2290
- Sivapragasam M, Rotondo F, Ricardo VL, Scheithauer BW, Cusimano M, Syro LV, Kovacs K. MicroRNAs in the Human Pituitary. Endocrine Pathology. 2011;22:134-143. doi: 10.1007/s12022-011-9167-6
- Di leva А, Butz Н, Niamah М, Rotondo F, De Rosa, Sav A, Yousef GM, Kovacs K, Cusimano MD. MicroRNAs as Biomarkers in Pituitary Tumors. Neurosurgery. 2014;75:181-189. doi: 10.1227/NEU.0000000000000369
- Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovascular Research. 2012;93(4):555-562. doi: 10.1093/cvr/cvr266
- Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Research. 2011;39(16):7223-7233. doi:org/10.1093/nar/gkr254
- Wagner J, Riwanto M, Besler C et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arteriosclerosis Thrombosis, and Vascular Biology. 2013;33(6):1392-1400. doi: 10.1161/atvbaha.112.300741
- Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology. 2007;9(6):654-659. doi: 10.1038/ncb1596
- Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nature Reviews Immunology. 2002;2(8):569-579.
- Hergenreider E, Heydt S, Treguer K et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature Cell Biology. 2012;14(3):249-256. doi: 10.1038/ncb2441
- Laffont B, Corduan A, Plé H et al. Activated platelets can deliver mRNA regulatory Ago2 microRNA complexes to endothelial cells via microparticles. Blood. 2013;122(2):253-261. doi: 10.1182/blood-2013-03-492801
- Zitvogel L, Regnault A, Lozier A et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nature Medicine. 1998;4(5):594-600. doi: 10.1038/nm0598-594
- Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for premetastatic niche formation: old sayings and new thoughts. Seminars in Cancer Biology. 2011;21(2):139-146. doi: 10.1016/j.semcancer.2011.01.002
- Ristorcelli E, Beraud E, Verrando P et al. Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB Journal.2008;22(9):3358-3369. doi: 10.1096/fj.07-102855
- Ohshima K, Inoue K, Fujiwara A et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010;5(10):e13247. doi: 10.1371/journal.pone.0013247
- Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT et al. Real-time quanitification of microRNAs by stem-loop RTPCR. Nucleic Acids Research. 2005;33:e179. doi: 10.1093/nar/gni178
- Várallyay E, Burgyán J, Havelda Z. MicroRNA detection by northern blotting using locked nucleic acid probes. Nature Protocols. 2008;3:190-196. doi: 10.1038/nprot.2007.528
- Erson AE, Petty EM. MicroRNAs in development and disease. Clinical Genetics. 2008;74:296-306. doi: 10.1111/j.1399-0004.2008.01076.x
- Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Development Biology. 2007;302:1-12. doi: 10.1016/j.ydbio.2006.08.028
- Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences. 2004;101:2999-3004. doi: 10.1073/pnas.0307323101
- Zhu W, Qin W, Atasoy U, Sauter ER. Circulating microRNAs in breast cancer and healthy subjects. BMC Research Notes. 2009;2:89. doi: 10.1186/1756-0500-2-89
- Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecologic Oncology. 2009;112(1):55-59. doi: 10.1016/j.ygyno.2008.08.036
- Chen ZH, Zhang GL, Li HR et al. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. The Prostate. 2012;72(13):1443-1452. doi: 10.1002/pros.22495
- Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. International Journal of Cancer. 2009;127(1):118-126. doi: 10.1002/ijc.25007
- Tsujiura M, Ichikawa D, Komatsu S et al. Circulating microRNAs in plasma of patients with gastric cancers. British Journal of Cancer. 2010;102(7):1174-1179. doi: 10.1038/sj.bjc.6605608
- Yamamoto Y, Kosaka N, Tanaka M et al. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers. 2009;14(7):529-538. doi: 10.3109/13547500903150771
- Ho AS, Huang X, Cao H et al. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Translational Oncology. 2010;3(2):109-113. doi: 10.1593/tlo.09256
- Hu Z, Chen X, Zhao Y et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of nonsmall-cell lung cancer. Journal of Clinical Oncology. 2010;28(10):1721-1726. doi:/10.1200/jco.2009.24.9342
- Redova M, Poprach A, Nekvindova J et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. Journal of Translational Medicine. 2012;10:55. doi: 10.1186/1479-5876-10-55
- Mao X, Sun Y, Tang J. Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma. Neurological Sciences. 2014;35(2):233-238. doi: 10.1007/s10072-013-1491-9
- Bottoni A, Zatelli-Ferracin M, Tagliati F, Piccin D, Vignali C et al. Identification of differentially expressed microRNAs by Microarray: a possible role for microRNA genes in pituitary adenomas. Journal of Cellular Physiology. 2007;210:370-377. doi: 10.1002/jcp.20832
- Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Research. 2005;33:1290-1297. doi: 10.1093/nar/gki200
- Butz H, Likó I, Czirják S, Igaz P, Korbonits M, Rácz K, Patócs A. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas. Pituitary. 2010;14:112-124. doi: 10.1007/s11102-010-0268-x
- Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC. miR-15а, miR-16-1 down regulation in pituitary adenomas. Journal of Cellular Physiology. 2005;204:280-285. doi: 10.1002/jcp.20282
- Amaral FC, Torres N, Saggioro F et al. miRNAs differentially expressed in ACTH-secreting pituitary tumors. The Journal of Clinical Endocrinology and Metabolism. 2009;94:320-323. doi: 10.1210/jc.2008-1451
- Stilling G, Sun Z, Zhang S et al. MicroRNA differentially expression in ACTH-produsing pituitary tumors: up-regulation of MicroRNA-122 and 493 in pituitary carcinomas. Endocrine. 2010;38:67-75. doi: 10.1007/s12020-010-9346-0
- Huang W, Li MD. Differential allelic expression of dopamine D1 receptors gene is modulated by microRNA-504. Biological Psychiatry.2009;65:702-705. doi: 10.1016/j.biopsych.2008.11.024
- Tabon KE, Chang D, Kuzhikandathil EV. MicroRNA 142-3p mediated posttranscriptional regulation of D1 dopamine receptor expression. PloS ONE. 2012;7:e49288. doi: 10.1371/journal.pone.0049288
- Mao ZG, He DS, Zhou J et al. Differential expression of micro RNAs in GH-secreting pituitary adenomas. Diagnostic Pathology.2010,5:79. doi: 10.1186/1746-1596-5-79
Дополнительные файлы
![](/img/style/loading.gif)